NetworkNewsBreaks

FridayJul 22, 2022 10:31 am

NetworkNewsBreaks – DoubleDown Interactive Co. Ltd. (NASDAQ: DDI) Schedules August Extraordinary General Meeting

DoubleDown Interactive (NASDAQ: DDI), a leading developer and publisher of digital social casino games, will hold an extraordinary general meeting (“EGM”) of shareholders next month. The meeting is slated to begin on Aug. 25, 2022, at 10 p.m. ET. in Seoul. According to the announcement, the company’s board of directors will present several resolutions for shareholders to vote on. Those resolutions include the re-election of current directors In Keuk Kim, Joseph A. Sigrist, Ki Chul Kim and Haenam Kim as directors of the company for a new three-year term, effective Aug. 26, 2022, through Aug. 25, 2025; the election of Whanlim…

Continue Reading

ThursdayJul 21, 2022 2:58 pm

NetworkNewsBreaks – Golden Matrix Group Inc.’s (NASDAQ: GMGI) GMX-Ag System Facilitating Brand Expansion, Global Market Penetration

Golden Matrix (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems and gaming content, has been a key beneficiary of a trend that has seen hundreds of gambling platforms opt for white label product offerings from third-party providers. GMGI provides its end customers with access to a substantial portfolio of upwards of 10,000 games. “Golden Matrix Group has looked to cater to growing demand from online gaming platforms, most recently through the launch of its B2B aggregate gaming system, GMX-Ag. The turnkey iGaming system seeks to offer online platforms with an optimal casino, sportsbook and live gaming offering…

Continue Reading

ThursdayJul 21, 2022 2:40 pm

NetworkNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Issues Reminder for Upcoming Annual Shareholder Meeting

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today issued a reminder for its current shareholders regarding the upcoming annual shareholder meeting. Beginning at 9:30 a.m. ET on July 26, 2022, Mullen will conduct a required formal shareholder meeting, which will be followed by a company presentation by David Michery, CEO and chairman of Mullen Automotive. The in-person meeting will be held at the NASDAQ Building, 151 West 42nd Street, 10th Floor (West Cafe – Market Site Event Space), New York, NY 10036. Please note that NASDAQ requires registration (see instructions in press release) for all those planning…

Continue Reading

ThursdayJul 21, 2022 1:29 pm

NetworkNewsBreaks – Correlate Infrastructure Partners Inc. (CIPI) Reducing Site-Specific Energy Consumption, Deploying Energy Generation at Scale

Correlate Infrastructure Partners (OTCQB: CIPI) is among the companies that can help evaluate the grid’s sustainability in terms of green energy capabilities. “Through its subsidiaries, Correlate and Solar Site Design, Correlate Infrastructure Partners offers a comprehensive suite of proprietary clean energy assessment solutions for the commercial real estate industry,” reads a recent article. “The company also develops and finances renewable energy projects to make investment properties more efficient. Correlate Infrastructure Partners has identified a tremendous market opportunity in reducing site-specific energy consumption and deploying energy generation and efficiency solutions at scale. Studies show that commercial properties across the United States…

Continue Reading

ThursdayJul 21, 2022 1:18 pm

NetworkNewsBreaks – Astra Energy Inc. (ASRE) Releases Update for Shareholders

Astra Energy (OTC: ASRE), a renewable and waste-to-energy project developer and technology acquisition company, has shared a status update regarding recent company business development activity and successes. Highlights of the report include news that members of Astra’s executive team attended an Iftar dinner discussion in April; the discussion focused on Egypt's economic and fiscal outlook and included Dr. Mohamed Maait, Egypt’s minister of finance, and Dr. Rania Al-Mashat, the minister of international cooperation. Also in April, Astra COO Dan Claycamp and vice president of project development and planning Fred Nyanzi met with the president of the United Republic of Tanzania H.E. Samia…

Continue Reading

ThursdayJul 21, 2022 1:03 pm

NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Enters New Contract Expected to Generate Significant 2023 Revenue, Drive Accelerated Future Growth

Pressure BioSciences (OTCQB: PBIO) (“PBI”) is a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty testing services to the worldwide nutraceuticals, biotherapeutics and other industries. The company today announced its entry into an agreement with North Star Holdings (“NSH”) on the financial partnership for the development, production, distribution and commercial roll-out of NSH’s novel, effectively water-soluble, nanoemulsified CBD spray for topical use. In addition, PBI will partner with the NSH team on the development and distribution of additional nano-CBD containing products that the highly successful Colorado cannabis operator has already suggested. “John's years of…

Continue Reading

ThursdayJul 21, 2022 11:35 am

NetworkNewsBreaks – Sycamore Entertainment Group Inc. (SEGI) Featured in Bell2Bell Podcast

Sycamore Entertainment Group (OTC: SEGI), a diversified entertainment company, was featured in the Bell2Bell Podcast, a part of IBN’s (InvestorBrandNetwork) sustained effort to provide specialized content distribution via widespread syndication channels. Edward Sylvan, co-founder and CEO of Sycamore Entertainment Group, joined the latest episode to provide an introduction to the company and discuss its business model. “Sycamore Entertainment Group is a full-service marketing and distribution company that operates in film and television within the entertainment industry. What that means is that we’re the people who take finished films and television shows and get them to the mainstream audience either through…

Continue Reading

ThursdayJul 21, 2022 11:28 am

NetworkNewsBreaks – Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Reports on First Full-Year Revenue, Issues KWC Status Update

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, has released an update on its both its financial and corporate status. According to the announcement, the company released its first end-of-year earnings report in May, which showed $1.5 million annual revenue and a growth in net assets from $2.1 million in 2020 to $10 million by 2021 year end, a 500% year-over-year increase. In addition, the company’s Ketamine Wellness Centers (“KWC”) are reporting impressive growth, offering an estimated 100,000 treatments so far at its 13 operational, state-of-the-art clinics; the company…

Continue Reading

WednesdayJul 20, 2022 3:03 pm

NetworkNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Unlocking ‘New Frontiers of Discovery’ with Kernel Flow

Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various conditions, has announced preliminary data from a feasibility study using Kernel Flow. The results indicate that ketamine-induced changes in functional connectivity last for several days after administration of the substance. “Kernel Flow is the first easy-to-use, wearable device that collects and measures real-time brain activity before, during and after a psychedelic experience. Using the device, the study successfully measured the neuro-effect of ketamine over 11 days, confirming changes in functional connectivity that are consistent with current scientific research,” a recent article reads.…

Continue Reading

WednesdayJul 20, 2022 2:43 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Expanding Patient Eligibility in Potentially Pivotal Berubicin Trial

CNS Pharmaceuticals (NASDAQ: CNSP) recently announced that its global clinical trial for a potentially pivotal brain cancer treatment will expand patient eligibility following an amendment to its protocol for the study. “CNS has been enrolling patients in its phase II clinical trial for novel drug candidate Berubicin, which has shown promise in fighting the aggressive brain cancer glioblastoma (‘GBM’),” explains a recent article. “The trial will compare Berubicin’s performance to the standard of care chemotherapy agent Lomustine, aiming to establish that Berubicin is at least as effective as Lomustine and potentially better because of Berubicin’s reported capacity to cross the…

Continue Reading